IgG based B7-H3/CD3 bispecific antibody (BiconY Therapeutics)

N/A

Report date: 2026/03/19 17:12:12

Base Information

Drug NameIgG based B7-H3/CD3 bispecific antibody (BiconY Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD276Anti-CD3

TargetsCD276 antigenT cell surface glycoprotein CD3

Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiconY Therapeutics Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesBiconY Therapeutics Gmbh

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A